Ionis Pharmaceuticals in (ions 0.125 12/15/24)
13F holders, Q1 2024 (March 31)4holders
$0.94avg. 13F price*
At the end of Q1 2024, 4 institutions reported holding Ionis Pharmaceuticals in (ions 0.125 12/15/24) in their 13F filings. The largest holders were Sonora Investment Management Group, LLC ($14.8M), Kestra Private Wealth Services, LLC ($19K) and Envestnet Asset Management Inc. ($14K).
- Company
- Ionis Pharmaceuticals in (ions 0.125 12/15/24)
- CUSIP
- 462222AB6
- Latest filing quarter
- Q3 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $14K |
| Exits | 0 | $0 |
Ownership 4 holders
| Sonora Investment Management Group, LLC | 1.17% | Reduce -7.3% | 15,741,000 | $14.8M |
| Kestra Private Wealth Services, LLC | 0.00% | No change | 20,000 | $19K |
| Envestnet Asset Management Inc. | 0.00% | New | 15,000 | $14K |
| Brighton Jones LLC | 0.00% | No change | 10,000 | $9K |
"% of holder's portfolio" is IONIS PHARMACEUTICALS IN (IONS 0.125 12/15/24)'s weight in each manager's 13F, not the share of Ionis Pharmaceuticals in (ions 0.125 12/15/24) the manager owns.